Plato Investment Management Ltd Sells 6,153 Shares of Cigna Group $CI

Key Points

• Plato Investment Management Ltd reduced its stake in Cigna Group by 36.1%, selling 6,153 shares during the first quarter, leaving it with 10,887 shares valued at approximately $3.62 million.
• Recent insider trading saw Nicole S. Jones sell 28,526 shares at an average price of $300, significantly decreasing her ownership by 52.66%.
• Analysts have a strong consensus rating for Cigna Group with two "Strong Buy" and fifteen "Buy" ratings, and a target price of around $374.76.

Plato Investment Management Ltd lowered its stake in shares of Cigna Group (NYSE:CI - Free Report) by 36.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,887 shares of the health services provider's stock after selling 6,153 shares during the quarter. Plato Investment Management Ltd's holdings in Cigna Group were worth $3,621,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC raised its holdings in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock valued at $1,032,000 after purchasing an additional 318 shares during the last quarter. Focus Partners Wealth increased its stake in Cigna Group by 11.6% in the 4th quarter. Focus Partners Wealth now owns 23,808 shares of the health services provider's stock valued at $6,579,000 after buying an additional 2,483 shares during the last quarter. Jefferies Financial Group Inc. lifted its position in shares of Cigna Group by 184.8% during the 4th quarter. Jefferies Financial Group Inc. now owns 20,037 shares of the health services provider's stock worth $5,533,000 after buying an additional 13,001 shares in the last quarter. New England Asset Management Inc. boosted its stake in shares of Cigna Group by 29.3% in the 4th quarter. New England Asset Management Inc. now owns 18,835 shares of the health services provider's stock worth $5,201,000 after buying an additional 4,270 shares during the last quarter. Finally, NDVR Inc. grew its holdings in shares of Cigna Group by 5.4% in the fourth quarter. NDVR Inc. now owns 915 shares of the health services provider's stock valued at $253,000 after acquiring an additional 47 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CI. TD Cowen upgraded Cigna Group to a "strong-buy" rating in a report on Monday, June 23rd. Robert W. Baird set a $372.00 target price on Cigna Group in a research note on Thursday, August 14th. Truist Financial set a $375.00 price target on shares of Cigna Group in a report on Tuesday, September 2nd. Barclays raised their price objective on shares of Cigna Group from $354.00 to $383.00 and gave the stock an "overweight" rating in a report on Thursday, September 4th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and issued a $371.00 target price on shares of Cigna Group in a research note on Thursday, June 26th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $374.76.

Cigna Group Price Performance

Shares of NYSE:CI opened at $302.13 on Wednesday. The firm has a market capitalization of $80.65 billion, a PE ratio of 16.49, a P/E/G ratio of 0.88 and a beta of 0.48. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The company has a 50-day moving average price of $296.44 and a two-hundred day moving average price of $312.11. Cigna Group has a twelve month low of $256.89 and a twelve month high of $370.83.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. During the same period in the previous year, the business earned $6.72 EPS. Cigna Group's revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group's dividend payout ratio (DPR) is 32.97%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.